In Brief: House FY 1997 Budget Resolution
This article was originally published in The Gray Sheet
Executive SummaryHouse FY 1997 Budget Resolution: GOP leaders recommend savings of $662 mil. in FDA's budget authority through 2002 by structurally reforming the agency's "review process," according to a budget summary. The House plan assumes passage of House/Senate FDA reform legislation proposals, both of which include some type of third-party system for device review and good manufacturing practices inspections...
You may also be interested in...
Companion diagnostics are needed increasingly by pharma companies to justify the safety and effectiveness of their products. With specific first-time EU regulation of these products within sight – and urgently needed – is there a risk of delays to these products being able to demonstrate compliance?
Draft policy moots crowdfunding for high-cost rare diseases alongside financial support for those "amenable to one-time treatment" but falls way short of some patient groups' expectations.
India’s Hilleman Laboratories says it’s aiming to develop an affordable vaccine that will target pregnant women in low- and middle-income countries to prevent Group B Streptococcus, a potentially fatal infection passed to babies during childbirth.